Industry

Global Phase 3 MANEUVER study of pimicotinib in tenosynovial giant cell tumor (TGCT) met the primary endpoint, demonstrating objective response rate at week 25 of 54.0% versus 3.2% for placebo (p<0.0001) MANEUVER met all five key secondary endpoints, with statistically significant and clinically meaningful improvements in pain, stiffness, range of motion, physical function, and decrease … [Read more…]

BOSTON–(BUSINESS WIRE)–Following its successful US launch and FDA clearance, Empatica is proud to announce that EpiMonitor, its pioneering epilepsy monitoring solution, is now a CE-certified device according to EU Medical Device Regulation 2017/745 and available in Europe. EpiMonitor is a game-changing, medical-grade wearable and app combination that revolutionizes epilepsy care, providing seizure detection and alerting … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#EndPeriodPoverty–AIDS Healthcare Foundation (AHF) joins the world in commemorating Menstrual Health Day with a series of activations across many of our 48 countries of operation — aimed at breaking stigma, promoting menstrual health equity, and protecting the health and futures of women and girls/people who menstruate. Menstrual Health Day is observed annually on … [Read more…]

CHICAGO–(BUSINESS WIRE)–This is a correction of the announcement. The number of shares and expected proceeds from the private placement have been corrected to 463,332 shares and approximately $695,000. All other aspects of the announcement remain the same. The updated release reads: MAIA BIOTECHNOLOGY ANNOUNCES PRIVATE PLACEMENT OF APPROXIMATELY $695,000 MAIA Biotechnology, Inc., (NYSE American: MAIA) … [Read more…]

PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a fireside chat at the TD Cowen: 6th Annual Oncology Innovation Summit: Insights for ASCO & EHA to take place on May 27-28, 2025. TD … [Read more…]

Findings Released in ASCO Abstract Validate Life-Saving Impact of AION TempShield’s Long-Term Temperature Tracking for Cancer Patients. SCHENECTADY, N.Y.–(BUSINESS WIRE)–AION Biosystems today announced a major breakthrough in cancer care: TempShield™, an AI-powered wearable thermometer, has been shown to reduce mortality by 90% and inpatient days by 79% in cancer patients undergoing chemotherapy. These results—announced in … [Read more…]

Caregiving, Funded in Part by Lead and Founding Sponsor Otsuka, Underscores the Urgent Need for Systemic Reform and Sustainable Support for Family Caregivers PRINCETON, N.J.–(BUSINESS WIRE)–Otsuka America Pharmaceutical, Inc., the lead, founding sponsor of a new PBS and WETA documentary created with executive producer and award-winning actor Bradley Cooper, announces that Caregiving is now available … [Read more…]

BAAR, Switzerland–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor events. PANOVA-3 Investor Event, May 31, 2025: Novocure will host investors on Saturday, May 31 at 8:00 p.m. ET / 7:00 p.m. CT in Chicago to review data from the successful Phase 3 PANOVA-3 clinical trial in unresectable, locally advanced … [Read more…]

Repeated scandals, an attitude that is suspected as concealment and a lack of succession planning at Toho HD indicate its serious breakdown in corporate governance The Board of Directors continues to reject reasonable proposals for operational improvement, obstructing the Company’s path to sustainable value creation The persistent failure to address compliance issues risks alienating its … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–#IRConferences–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team will present and host 1×1 meetings at the upcoming investor conferences, detailed below. Jefferies Global Healthcare Conference Dates: June 3 – 5 2025 | New York, USA The executive team will … [Read more…]